Literature DB >> 12659712

The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivo.

H Verhagen1, O I Aruoma, J H M van Delft, L O Dragsted, L R Ferguson, S Knasmüller, B L Pool-Zobel, H E Poulsen, G Williamson, S Yannai.   

Abstract

There is increasing evidence that chemicals/test substances cannot only have adverse effects, but that there are many substances that can (also) have a beneficial effect on health. As this journal regularly publishes papers in this area and has every intention in continuing to do so in the near future, it has become essential that studies reported in this journal reflect an adequate level of scientific scrutiny. Therefore a set of essential characteristics of studies has been defined. These basic requirements are default properties rather than non-negotiables: deviations are possible and useful, provided they can be justified on scientific grounds. The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivo concern the following areas: (1) Hypothesis-driven study design; (2) The nature of the test substance; (3) Valid and invalid test systems; (4) The selection of dose levels and gender; (5) Reversal of the effects induced by oxidants, carcinogens and mutagens; (6) Route of administration; (7) Number and validity of test variables; (8) Repeatability and reproducibility; (9) Statistics; and (10) Quality Assurance.

Mesh:

Substances:

Year:  2003        PMID: 12659712     DOI: 10.1016/s0278-6915(03)00025-5

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  10 in total

Review 1.  Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers.

Authors:  Lars O Dragsted
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

2.  Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study.

Authors:  Holger Langhof; William Wei Lim Chin; Susanne Wieschowski; Carole Federico; Jonathan Kimmelman; Daniel Strech
Journal:  Br J Pharmacol       Date:  2018-10-01       Impact factor: 8.739

3.  The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells.

Authors:  Mar Larrosa; Francisco A Tomás-Barberán; Juan Carlos Espín
Journal:  Eur J Nutr       Date:  2004-01-12       Impact factor: 5.614

4.  Antidiabetic and in vitro antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic rats.

Authors:  D K Patel; R Kumar; S K Prasad; K Sairam; S Hemalatha
Journal:  Asian Pac J Trop Biomed       Date:  2011-08

5.  Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats.

Authors:  Shucha Zhang; G A Nagana Gowda; Vincent Asiago; Narasimhamurthy Shanaiah; Coral Barbas; Daniel Raftery
Journal:  Anal Biochem       Date:  2008-08-20       Impact factor: 3.365

Review 6.  Medicinally important aromatic plants with radioprotective activity.

Authors:  Ravindra M Samarth; Meenakshi Samarth; Yoshihisa Matsumoto
Journal:  Future Sci OA       Date:  2017-09-21

Review 7.  Utilization of cytogenetic biomarkers as a tool for assessment of radiation injury and evaluation of radiomodulatory effects of various medicinal plants - a review.

Authors:  Ravindra M Samarth; Meenakshi Samarth; Yoshihisa Matsumoto
Journal:  Drug Des Devel Ther       Date:  2015-09-25       Impact factor: 4.162

Review 8.  Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review.

Authors:  David Krauth; Tracey J Woodruff; Lisa Bero
Journal:  Environ Health Perspect       Date:  2013-06-14       Impact factor: 9.031

Review 9.  Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments.

Authors:  Valerie C Henderson; Jonathan Kimmelman; Dean Fergusson; Jeremy M Grimshaw; Dan G Hackam
Journal:  PLoS Med       Date:  2013-07-23       Impact factor: 11.069

10.  Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals.

Authors:  Jan Vollert; Esther Schenker; Malcolm Macleod; Anton Bespalov; Hanno Wuerbel; Martin Michel; Ulrich Dirnagl; Heidrun Potschka; Ann-Marie Waldron; Kimberley Wever; Thomas Steckler; Tom van de Casteele; Bruce Altevogt; Annesha Sil; Andrew S C Rice
Journal:  BMJ Open Sci       Date:  2020-04-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.